AHZ
Director Trades
| Date | Director | Value |
|---|
Company News
Admedus agrees to sell CardioCel and VascuCel patch business to LeMaitre Vascular
Admedus (ASX: AHZ) shares have returned to trading after the structural heart company confirmed it would conduct a recapitalisation plan by selling its patch business to a US medical devices firm. In a statement to the market, Admedus announced that it had sold its CardioCel and VascuCel patch business to NASDAQ-listed LeMaitre Vascular for up […]
CE Mark approval paves way for Admedus to market tissue technology into Europe
Medical technology company Admedus (ASX: AHZ) has moved closer to increasing global sales of its Adapt tissue technology after receiving regulatory approval from European authorities for its CardioCel 3D and VascuCel products. The approval was in the form of CE Mark certification – which indicates conformity with health, safety, and environmental protection standards for products […]
Admedus recruits Cardiva to distribute ADAPT tissue scaffolds in Spain, Portugal
Cardiac medical device technologist Admedus (ASX: AHZ) has refined its worldwide sales strategy, signing up long-time operator Cardiva to distribute its ADAPT bio-scaffolding products in Spain and Portugal. The marketing and supply agreement announced to market today will start immediately and give the Australian medtech access to more than 120 professionals in the two countries. […]
Admedus attracts multimillion dollar investment for vaccine research
Medical technology company Admedus (ASX: AHZ) is on the brink of attracting at least $18 million to fund further research into its vaccine program. Admedus announced that its subsidiary Admedus Vaccines Pty Ltd has signed a letter of intent (LOI) with Hong Kong-based investor Star Bright Holding to kick off negotiations to establish a firm […]
Admedus delivers on shareholder pledge to expand US sales network
Biotech developer Admedus (ASX: AHZ) has signed a purchasing agreement with a major US-based group purchasing organisation (GPO) through its US subsidiary, Admedus Corporation – and delivered on a shareholder promise made in November last year. The 3-year agreement means Admedus will gain direct access to promote ADAPT, its flagship technology suite containing products such […]
Company Videos
No videos found.